Literature DB >> 20665375

Cell death and fibrogenesis.

Wajahat Mehal1, Avlin Imaeda.   

Abstract

Fibrosis is a common feature of chronic liver injury and is initiated by cell death inside the liver. Hepatocyte death results in apoptotic bodies and other cellular debris, which are phagocytosed by hepatic stellate cells (HSCs), resulting in their activation, proliferation, differentiation, and matrix deposition. This profibrotic effect of cellular death is balanced by an antifibrotic effect of HSC death. Many HSC survival signals are obtained from the extracellular matrix, and active proapoptotic signals are provided by immune cells, particularly natural killer (NK) cells. Quiescent HSCs are relatively resistant to apoptotic signals but become sensitive after activation. The important role of NK cells in inducing HSC apoptosis may explain the increased fibrosis associated with immune suppression (e.g., in the transplant recipient) and HIV infection. HSCs also undergo senescence, which limits their function and sensitizes them to apoptosis. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20665375      PMCID: PMC3219753          DOI: 10.1055/s-0030-1255352

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  51 in total

1.  Senescence of activated stellate cells: not just early retirement.

Authors:  Jörg Schrader; Jonathan Fallowfield; John P Iredale
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

2.  Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.

Authors:  Edwin S L Chan; Maria Carmen Montesinos; Patricia Fernandez; Avani Desai; David L Delano; Herman Yee; Allison B Reiss; Michael H Pillinger; Jiang-Fan Chen; Michael A Schwarzschild; Scott L Friedman; Bruce N Cronstein
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  c-Jun-N-terminal kinase dependent membrane targeting of CD95 in rat hepatic stellate cells.

Authors:  Alexandra Cariers; Roland Reinehr; Richard Fischer; Ulrich Warskulat; Dieter Häussinger
Journal:  Cell Physiol Biochem       Date:  2002

4.  AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers.

Authors:  Wilma Debernardi-Venon; Silvia Martini; Fiorella Biasi; Barbara Vizio; Angela Termine; Giuseppe Poli; Franco Brunello; Carlo Alessandria; Renato Bonardi; Giorgio Saracco; Mario Rizzetto; Alfredo Marzano
Journal:  J Hepatol       Date:  2007-02-09       Impact factor: 25.083

Review 5.  Fibrosis and cirrhosis reversibility - molecular mechanisms.

Authors:  Roben G Gieling; Alastair D Burt; Derek A Mann
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

6.  Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism.

Authors:  Joy X Jiang; Kenichiro Mikami; Vijay H Shah; Natalie J Torok
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

7.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Authors:  J P Iredale; R C Benyon; J Pickering; M McCullen; M Northrop; S Pawley; C Hovell; M J Arthur
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

8.  Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.

Authors:  R Botla; J R Spivey; H Aguilar; S F Bronk; G J Gores
Journal:  J Pharmacol Exp Ther       Date:  1995-02       Impact factor: 4.030

9.  Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition.

Authors:  Muhammad A Sohail; Ardeshir Z Hashmi; Wyel Hakim; Azuma Watanabe; Alexander Zipprich; Roberto J Groszmann; Jonathan A Dranoff; Natalie J Torok; Wajahat Z Mehal
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

10.  Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

Authors:  Pavel Taimr; Hajime Higuchi; Eva Kocova; Richard A Rippe; Scott Friedman; Gregory J Gores
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

View more
  33 in total

1.  Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.

Authors:  Leila Gobejishvili; Shirish Barve; Katja Breitkopf-Heinlein; Yan Li; JingWen Zhang; Diana V Avila; Steven Dooley; Craig J McClain
Journal:  J Pharmacol Exp Ther       Date:  2013-07-25       Impact factor: 4.030

Review 2.  Mechanisms of hepatic fibrogenesis.

Authors:  Ursula E Lee; Scott L Friedman
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

Review 3.  Fibrosis-dependent mechanisms of hepatocarcinogenesis.

Authors:  David Y Zhang; Scott L Friedman
Journal:  Hepatology       Date:  2012-06-29       Impact factor: 17.425

4.  Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.

Authors:  Joy X Jiang; Xiangling Chen; Nobuko Serizawa; Cédric Szyndralewiez; Patrick Page; Katrin Schröder; Ralf P Brandes; Sridevi Devaraj; Natalie J Török
Journal:  Free Radic Biol Med       Date:  2012-05-19       Impact factor: 7.376

Review 5.  Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.

Authors:  Nam-On Ku; Pavel Strnad; Heike Bantel; M Bishr Omary
Journal:  Hepatology       Date:  2016-04-04       Impact factor: 17.425

6.  Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.

Authors:  Jinu Kim; Sang Pil Yoon; Myron L Toews; John D Imig; Sung Hee Hwang; Bruce D Hammock; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-05

7.  Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt.

Authors:  Gang Deng; Xiang-Jun Huang; Hong-Wu Luo; Fei-Zhou Huang; Xun-Yang Liu; Yong-Heng Wang
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 8.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 9.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

10.  Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.

Authors:  Jinu Kim; John D Imig; Jun Yang; Bruce D Hammock; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.